The global medical cannabis market is expected to reach USD 88,488.01 million by 2030 from USD 17,218.02 million in 2022, growing at a CAGR of 22.76% during the forecast period of 2023 to 2030.
Market Segmentation
Global Medical Cannabis Market, By Product (Oil, Medical Cannabis Capsules, Patch, Whole Flower, Ground Flower, Vape Pen, Dried Medical Cannabis, Creams & Moisturizer, Masks & Serum, Cleanser, and Others), Source (Natural and Synthetic), Species (Cannabis Indica, Sativa, and Hybrid), Application (Alzheimer's Disease, Appetite Loss, Cancer, Inflammatory Bowel Diseases, Eating Disorders, Epilepsy, Autism, Mental Health Conditions, Multiple Sclerosis, Pain Management, Nausea, Muscle Spasms, Wasting Syndrome (Cachexia), Elevate Mood, Depression and Sleep Disorders, Anxiety, and Others), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC), Delta-8-tetrahydrocannabinol, Cannabinol (CBN), Cannabicyclol (CBL), Cannabichromene (CBC), Cannabigerol (CBG), and Others), Treatment Type (Expectorant, Antiviral, Analgesic, Aphrodisiac, Psychedelic, and Others), Route of Administration (Oral Solutions and Capsules, Smoking, Vaporizers, Topicals, and Others), End User (Pharmaceutical Industry, Research and Development Centers, Homecare Setting, Hospital, Rehab Centers, and Others), Distribution Channel (B2B and B2C), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Netherlands, Russia, Denmark, Switzerland, Turkey, Sweden, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, New Zealand, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Ethiopia, U.A.E., and Rest of Middle East and Africa) - Industry Trends and Forecast to 2030.
Overview of Global Medical Cannabis Market Dynamics
Driver
Increased medical use of cannabis
Restraint
The complex regulatory structure for the usage of cannabis
Opportunity
Novel product development with increasing R&D activities
Market Players
Some of the major market players operating in the global medical cannabis market are:
- MediPharm Labs Inc.
- Tilray
- Aurora Cannabis
- JAZZ Pharmaceuticals Inc. (GW Pharmaceuticals plc)
- HEXO Corp. (Zenabis Global Ltd)
- Cresco Labs
- Peace Naturals Project Inc.
- CANOPY GROWTH CORPORATION
- Medical Marijuana, Inc.
- Seed Cellar
- EcoGen Biosciences
- CANNABIS SEEDS USA
- Seeds For Me
- HUMBOLDT SEED COMPANY
- Extractas
- World Class Cannabis Seeds (Crop King Seeds)
- BARNEY'S FARM
- FOLIUM BIOSCIENCES
- PharmaHemp
- Elixinol Global Limited
- ENDOCA
- Harmony
- MARY'S nutritionals, LLC
- Pure Ratios
- Greenwich Biosciences, Inc.
- Upstate Elevator Supply Co.
- Apothecanna
- BOL Pharma
- IDT Australia
TABLE OF CONTENTS
1 INTRODUCTION 157
- 1.1 OBJECTIVES OF THE STUDY 157
- 1.2 MARKET DEFINITION 157
- 1.3 OVERVIEW OF THE GLOBAL MEDICAL CANNABIS MARKET 157
- 1.4 LIMITATIONS 159
- 1.5 MARKETS COVERED 160
2 MARKET SEGMENTATION 169
- 2.1 MARKETS COVERED 169
- 2.2 GEOGRAPHICAL SCOPE 170
- 2.3 YEARS CONSIDERED FOR THE STUDY 171
- 2.4 CURRENCY AND PRICING 171
- 2.5 DBMR TRIPOD DATA VALIDATION MODEL 172
- 2.6 MULTIVARIATE MODELLING 175
- 2.7 PRODUCT LIFELINE CURVE 175
- 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 176
- 2.9 DBMR MARKET POSITION GRID 177
- 2.10 MARKET APPLICATION COVERAGE GRID 179
- 2.11 VENDOR SHARE ANALYSIS 180
- 2.12 SECONDARY SOURCES 181
- 2.13 ASSUMPTIONS 181
3 EXECUTIVE SUMMARY 182
4 PREMIUM INSIGHTS 185
- 4.1 PESTEL ANALYSIS 188
- 4.2 PORTER'S FIVE FORCES 189
5 INDUSTRY INSIGHTS 190
- 5.1 INDUSTRY INSIGHTS PATENT ANALYSIS 190
- 5.2 DRUG TREATMENT RATE BY MATURED MARKETS 197
- 5.3 DEMOGRAPHIC TRENDS: IMPACTS ON ALL INCIDENCE RATES 198
- 5.4 PATIENT FLOW DIAGRAM 199
- 5.5 KEY PRICING STRATEGIES 200
- 5.6 KEY PATIENT ENROLLMENT STRATEGIES 201
6 REGULATORY SCENARIO 202
- 6.1 U.S. 202
- 6.2 CANADA 202
- 6.3 MEXICO 202
- 6.4 GERMANY 203
- 6.5 ITALY 203
- 6.6 U.K. 203
- 6.7 SWITZERLAND 203
- 6.8 FRANCE 203
- 6.9 RUSSIA 203
- 6.10 SPAIN 203
- 6.11 HUNGARY 203
- 6.12 BELGIUM 203
- 6.13 AUSTRALIA 204
- 6.14 THAILAND 204
- 6.15 JAPAN 204
- 6.16 CHINA 204
- 6.17 NEW ZEALAND 204
- 6.18 SINGAPORE 204
- 6.19 INDIA 204
- 6.20 MALAYSIA 205
- 6.21 PHILIPPINES 205
- 6.22 BRAZIL 205
- 6.23 ARGENTINA 205
- 6.24 SOUTH AFRICA 205
- 6.25 U.A.E. 205
7 MARKET OVERVIEW 206
- 7.1 DRIVERS 207
- 7.1.1 INCREASED USE OF CANNABIS IN MEDICINES 207
- 7.1.2 LEGALIZATION OF CANNABIS 207
- 7.1.3 STRATEGIC INITIATIVES TAKEN BY KEY PLAYERS 207
- 7.1.4 RISE IN THE PREVALENCE OF DISEASES THAT REQUIRE THE USE OF CANNABIS 208
- 7.2 RESTRAINTS 209
- 7.2.1 COMPLEX REGULATORY STRUCTURE FOR THE USAGE OF CANNABIS 209
- 7.2.2 ADVERSE EFFECTS DUE TO LONG-TERM USE 209
- 7.2.3 HIGH-COST PURCHASING AND RUSH FOR PREMIUM QUALITY 210
- 7.3 OPPORTUNITIES 210
- 7.3.1 NOVEL PRODUCT DEVELOPMENT WITH INCREASING R&D ACTIVITIES 210
- 7.3.2 INCREASED ADOPTION OF CANNABIS FOR RECREATIONAL PURPOSES 210
- 7.3.3 GROWING GERIATRIC POPULATION 211
- 7.4 CHALLENGES 211
- 7.4.1 RISE OF THE CANNABIS BLACK MARKET 211
- 7.4.2 SIDE EFFECTS RELATED TO THE USE OF CANNABIS 212
- 7.4.3 SHORTAGE OF SKILLED PERSONNEL 212
8 GLOBAL MEDICAL CANNABIS MARKET, BY PRODUCT 213
- 8.1 OVERVIEW 214
- 8.2 OIL 218
- 8.2.1 OIL, BY TYPE 218
- 8.2.1.1 CBD OIL CONCENTRATES 218
- 8.2.1.2 CBD VAPE OIL 219
- 8.2.1.3 CBD TINCTURES 219
- 8.2.2 OIL, BY SOURCE 219
- 8.2.2.1 HEMP BASED 219
- 8.2.2.2 MARIJUANA BASED 219
- 8.2.3 OIL, BY SPECIES 219
- 8.2.3.1 SATIVA 219
- 8.2.3.2 HYBRID 220
- 8.2.3.3 CANNABIS INDICA 220
- 8.2.4 OIL, BY PRODUCT TYPE 220
- 8.2.4.1 BRANDED 220
- 8.2.4.1.1 PENGUIN CBD OIL 220
- 8.2.4.1.2 FAB CBD OIL 221
- 8.2.4.1.3 GREEN ROADS BROAD SPECTRUM CBD OIL 221
- 8.2.4.1.4 OTHERS 221
- 8.2.4.2 GENERIC 221
- 8.3 DRIED MEDICAL CANNABIS 221
- 8.3.1 CANNABIS INDICA 222
- 8.3.2 SATIVA 222
- 8.3.3 HYBRID 222
- 8.4 MEDICAL CANNABIS CAPSULES 223
- 8.4.1 MEDICAL CANNABIS CAPSULES, BY TYPE 223
- 8.4.1.1 OIL BASED CANNABIS CAPSULES 224
- 8.4.1.2 POWDER BASED CANNABIS CAPSULES 224
- 8.4.1.3 LIQUID BASED CANNABIS CAPSULES 224
- 8.4.1.4 OTHERS 224
- 8.4.2 MEDICAL CANNABIS CAPSULES, BY CONCENTRATES 224
- 8.4.2.1 HIGH CBD CAPSULES DIGITAL 224
- 8.4.2.2 HIGH THC CAPSULE 224
- 8.4.2.3 THC/CBD BALANCED CAPSULE 225
- 8.4.2.4 CBD ISOLATE CAPSULE 225
- 8.4.3 MEDICAL CANNABIS CAPSULES, BY SPECIES 225
- 8.4.3.1 SATIVA 225
- 8.4.3.2 CANNABIS INDICA 225
- 8.4.4 MEDICAL CANNABIS CAPSULES, BY PRODUCT TYPE 225
- 8.4.4.1 BRANDED 226
- 8.4.4.1.1 JOY NUTRITION 226
- 8.4.4.1.2 MEDTERRA ISOLATE CBD GEL CAPSULES 226
- 8.4.4.1.3 LAZARUS NATURALS 226
- 8.4.4.1.4 OTHERS 226
- 8.4.4.2 GENERIC 226
- 8.5 VAPE PEN 226
- 8.5.1 VAPE PEN, BY SPECIES 227
- 8.5.1.1 SATIVA 227
- 8.5.1.2 HYBRID 227
- 8.5.1.3 CANNABIS INDICA 228
- 8.5.2 VAPE PEN, BY PRODUCT TYPE 228
- 8.5.2.1 BRANDED 228
- 8.5.2.1.1 KANDYPENS RUBI 228
- 8.5.2.1.2 SOL E-NECTAR COLLECTOR 228
- 8.5.2.1.3 PAX ERA PRO-OIL VAPE PEN 229
- 8.5.2.2 GENERIC 229
- 8.6 WHOLE FLOWER 229
- 8.6.1 WHOLE FLOWER, SPECIES 229
- 8.6.1.1 SATIVA 230
- 8.6.1.2 HYBRID 230
- 8.6.1.3 CANNABIS INDICA 230
- 8.6.2 WHOLE FLOWER, PRODUCT TYPE 230
- 8.6.2.1 BRANDED 231
- 8.6.2.1.1 ASTER FARMS 231
- 8.6.2.1.2 RA FLOWER 231
- 8.6.2.1.3 BAD APPLE 231
- 8.6.2.2 GENERIC 231
- 8.7 CREAMS & MOISTURIZER 232
- 8.7.1 CREAMS & MOISTURIZER, BY SPECIES 232
- 8.7.1.1 SATIVA 233
- 8.7.1.2 HYBRID 233
- 8.7.1.3 CANNABIS INDICA 233
- 8.7.2 CREAMS & MOISTURIZER, BY PRODUCT TYPE 233
- 8.7.2.1 BRANDED 233
- 8.7.2.1.1 CBDFX MUSCLE & JOINT 234
- 8.7.2.1.2 ASPEN GREEN MUSCLE RELIEF COOLING CREAM 234
- 8.7.2.1.3 MEDTERRA PAIN CREAM 234
- 8.7.2.2 GENERIC 234
- 8.8 GROUND FLOWER 234
- 8.8.1 GROUND FLOWER, BY SPECIES 235
- 8.8.1.1 SATIVA 235
- 8.8.1.2 HYBRID 235
- 8.8.1.3 CANNABIS INDICA 235
- 8.8.2 GROUND FLOWER, BY PRODUCT TYPE 235
- 8.8.2.1 BRANDED 236
- 8.8.2.1.1 ASTER FARMS 236
- 8.8.2.1.2 RA FLOWER 236
- 8.8.2.1.3 BAD APPLE 236
- 8.8.2.2 GENERIC 236
- 8.9 PATCH 237
- 8.9.1 PATCH, BY TYPE 237
- 8.9.1.1 RESERVOIR 237
- 8.9.1.2 LAYER DRUG-IN-ADHESIVE 237
- 8.9.1.3 OTHERS 238
- 8.9.2 PATCH, BY SPECIES 238
- 8.9.2.1 SATIVA 238
- 8.9.2.2 CANNABIS INDICA 238
- 8.9.2.3 HYBRID 238
- 8.9.3 PATCH, BY PRODUCT TYPE 238
- 8.9.3.1 BRANDED 238
- 8.9.3.1.1 HEMP BOMBS 239
- 8.9.3.1.2 PUREKANA 239
- 8.9.3.1.3 PURE RATIOS 239
- 8.9.3.1.4 RESERVOIR 239
- 8.9.3.2 GENERIC 239
- 8.10 MASKS & SERUM 240
- 8.10.1 MASKS & SERUM, BY SPECIES 240
- 8.10.1.1 SATIVA 241
- 8.10.1.2 CANNABIS INDICA 241
- 8.10.1.3 HYBRID 241
- 8.10.2 MASKS & SERUM, BY PRODUCT TYPE 241
- 8.10.2.1 BRANDED 241
- 8.10.2.1.1 BUMP & SMOOTH CBD 241
- 8.10.2.1.2 FACIAL ESSENCE 242
- 8.10.2.1.3 OTHERS 242
- 8.10.2.2 GENERIC 242
- 8.11 CLEANSER 242
- 8.11.1 CLEANSER, BY SPECIES 242
- 8.11.1.1 SATIVA 243
- 8.11.1.2 HYBRID 243
- 8.11.1.3 CANNABIS INDICA 243
- 8.11.2 CLEANSER, BY PRODUCT TYPE 243
- 8.11.2.1 BRANDED 244
- 8.11.2.1.1 KIEHL'S 244
- 8.11.2.1.2 CBD 101 244
- 8.11.2.1.3 OTHERS 244
- 8.11.2.2 GENERIC 244
- 8.12 OTHERS 245
9 GLOBAL MEDICAL CANNABIS MARKET, BY SPECIES 246
- 9.1 OVERVIEW 247
- 9.2 SATIVA 250
- 9.3 HYBRID 251
- 9.4 CANNABIS INDICA 252
10 GLOBAL MEDICAL CANNABIS MARKET, BY DERIVATIVES 253
- 10.1 OVERVIEW 254
- 10.2 CANNABIDIOL (CBD) 257
- 10.3 TETRAHYDROCANNABINOL (THC)/DELTA-8-TETRAHYDROCANNABINOL 257
- 10.4 CANNABIGEROL (CBG) 258
- 10.5 CANNABICHROMENE (CBC) 259
- 10.6 CANNABINOL (CBN) 260
- 10.7 CANNABICYCLOL (CBL) 261
- 10.8 OTHERS 262
11 GLOBAL MEDICAL CANNABIS MARKET, BY APPLICATION 263
- 11.1 OVERVIEW 264
- 11.2 PAIN MANAGEMENT 268
- 11.2.1 PAIN MANAGEMENT, BY TYPE 268
- 11.2.1.1 CHRONIC PAIN 268
- 11.2.1.2 NON-CANCER CHRONIC PAIN 269
- 11.2.1.3 NEUROLOGICAL PAIN 269
- 11.2.2 PAIN MANAGEMENT, BY PRODUCT 269
- 11.2.2.1 OIL 269
- 11.2.2.2 DRIED MEDICAL CANNABIS 269
- 11.2.2.3 MEDICAL CANNABIS CAPSULES 269
- 11.2.2.4 PATCH 270
- 11.2.2.5 GROUND FLOWER 270
- 11.2.2.6 CREAMS & MOISTURIZER 270
- 11.2.2.7 VAPE PEN 270
- 11.2.2.8 WHOLE FLOWER 270
- 11.2.2.9 MASKS & SERUM 270
- 11.2.2.10 CLEANSER 270
- 11.2.2.11 OTHERS 270
- 11.3 ANXIETY 270
- 11.3.1 OIL 271
- 11.3.2 DRIED MEDICAL CANNABIS 271
- 11.3.3 MEDICAL CANNABIS CAPSULES 272
- 11.3.4 PATCH 272
- 11.3.5 GROUND FLOWER 272
- 11.3.6 CREAMS & MOISTURIZER 272
- 11.3.7 VAPE PEN 272
- 11.3.8 WHOLE FLOWER 272
- 11.3.9 MASKS & SERUM 272
- 11.3.10 CLEANSER 272
- 11.3.11 OTHERS 272